A comprehensive study on muscle paralysis linked with botulism disease

Abstract

Botulism is a neuromuscular paralysis–causing disease that stems from the action of the Clostridium botulinum neurotoxin (BoNT). This toxin can block acetylcholine release from nerve terminals, resulting in extreme muscle weakness or paralysis. BoNT produced by local infection leads to wound botulism, which is a type of foodborne disease involving the ingestion of BoNT-contaminated food products. Symptoms of botulism are due to muscle paralysis, which can lead to respiratory distress and, in severe cases, death. The mechanisms and implications of botulism on muscle function have not been addressed in detail. The findings of this study revealed the relationship between various BoNTs and the site of muscle impairment in murine C2C12 myoblast cells, offering new insight into muscle pathology caused by BoNT treatment. A comprehensive study based on various botulinum neurotoxins (BoNTs) was performed, and the effect of BoNT-producing muscle impairment was examined. The relationship between BoNTs and neuromuscular impairment is poorly understood, but direct muscle impairment studies were scarce and have not been performed. The significant study findings report at least 70% motor neuron impairment, similar to that of non-botulism studies. Treatment in a distancia.-dependent manner. While both the slow- and fast-type muscle cell lineages of C2C12 were reported in weight. In this context, botulinum neurotoxin causes long-lasting (Up to or more than a year) muscle weakness in the injection site of people after local treatment (Makarem Oliveira et al., 2022). The work is focused on examining new muscle pathology as muscle changes in the absence of nerve terminal damage. Qualified and comprehensive analyses encompassing different BoNTs involved in this study are conducted.